Comprehensive genomic profiling of matched ctDNA and tissue from patients with four common cancers enrolled to the NCI-MATCH trial.
Rini Pauly(Frederick National Laboratory for Cancer Research), Yuri Kotliarov(National Institutes of Health), Chris Karlovich(Clovis Oncology (United States)), A Chen(National Institutes of Health), Jennifer S. LoCoco(Illumina (United States)), Traci Pawlowski(Illumina (United States)), Lisa M. McShane(National Cancer Institute), Vishnuprabha Rahul Kannan(Frederick National Laboratory for Cancer Research), Sorena Rahmanian(University of California San Diego), Eric Greenbank(Frederick National Laboratory for Cancer Research), Peter J. O’Dwyer(University of Pennsylvania), Keith Flaherty(Massachusetts General Hospital), Li Chen(Frederick National Laboratory for Cancer Research), Stanley R. Hamilton(City of Hope), Biswajit Das(Frederick National Laboratory for Cancer Research), James H. Doroshow(National Institutes of Health), Ting-Chia Chang(Frederick National Laboratory for Cancer Research), Amanda Peach(Frederick National Laboratory for Cancer Research), Lyndsay N. Harris(National Institutes of Health)
Cited by 0
Related Papers
Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0
|Nature Protocols|2011|1.9k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Changes in circulating microRNA levels associated with prostate cancer
|British Journal of Cancer|2012|717
Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2015|664